The Sherlock Priority Score is the transparent math behind every "yes" and every "no" on Meridian's AI portfolio. Tuned to Meridian's board-approved weights. Recomputed weekly. Explainable to the CFO in one paragraph.
Prior authorization AI decisioning is the highest-priority initiative in Meridian's portfolio. Documented $18M annualized value against modest consequence and complexity. Named CMO sponsor. Existing PA workflow ready to absorb. Regulatory guardrails are the ONLY blocker — resolvable inside Sherlock's governance module.
“Prior Auth AI decisioning scored 87 of 100, the highest in Meridian's Q3 portfolio. The score reflects $18M annualized value (26.6 pts), a regulatory tailwind after CMS interoperability guidance (15.8 pts), and existing PA infrastructure that shortens time-to-value to 4 months (12.5 pts). The CMO is the named sponsor with $1.4M already committed (10.8 pts). Downside factors — regulatory exposure (−8.4), integration complexity (−3.6), and workflow change (−1.4) — are material but bounded by controls already documented in the Risk Registry. Recommendation: fund in Q3 with a Board-attested medical necessity guardrail.”